NCT07120191 An Open Label Data Collection Study of My Connect Post-Op, a Post-Operative Communication Tool
| NCT ID | NCT07120191 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Concentra AI, inc |
| Condition | Total Hip Replacement |
| Study Type | OBSERVATIONAL |
| Enrollment | 200 participants |
| Start Date | 2025-05-01 |
| Primary Completion | 2025-10-15 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 200 participants in total. It began in 2025-05-01 with a primary completion date of 2025-10-15.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This open label, multi-center study will collect data from the participant's use of My Connect Post-Op Software as a post-operative communication solution in supporting patient recovery through Technology-Assisted Conversation (TAC). The application will be tested by patients who have undergone total joint replacement as a post-op communication tool. Data will be collected on how effectively the product guides patients through their recovery, identifying potential complications, and providing appropriate recommendations based on structured question pairs.
Eligibility Criteria
Inclusion Criteria: Orthopedic patients scheduled for elective joint arthroplasty (single or double knee, or single or double hip replacement surgery). Age 22-80 years. Owns a smart phone. Speaks and understands written and spoken English. Ability to give written informed consent. Exclusion Criteria: Known diagnosis of a psychiatric disorder. Known opioid dependence in the Investigator's opinion that may complicate participation. Participation in another clinical trial investigating a drug, medical device, or a medical procedure in the 30 days preceding trial inclusion and throughout the duration of the trial. Any condition that in the Investigator's opinion may complicate or preclude the subject from participating in this trial, such as physical impairment or noncooperation
Frequently Asked Questions
Who can join the NCT07120191 clinical trial?
This trial is open to participants of all sexes, aged 22 Years or older, up to 80 Years, studying Total Hip Replacement. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07120191 currently recruiting?
Yes, NCT07120191 is actively recruiting participants. Visit ClinicalTrials.gov or contact Concentra AI, inc to inquire about joining.
Where is the NCT07120191 trial being conducted?
This trial is being conducted at Wichita, United States.
Who is sponsoring the NCT07120191 clinical trial?
NCT07120191 is sponsored by Concentra AI, inc. The trial plans to enroll 200 participants.